Robotic vs. Non-Robotic Single-Site Hysterectomy: Marchand Institute’s New Meta-Analysis Provides Clarity on Surgical Outcomes
FOR IMMEDIATE RELEASE
MESA, Ariz. — December 7, 2016
Dr. Marchand is very excited to announce that his new Surgical Technique, “The Marchand Salpingectomy – A 
Five Minute Procedure That Decreases the Risk of Ovarian Cancer for a Lifetime,” has been accepted for Presentation at the Annual American College of Surgeon’s Conference. The Video and Multimedia presentation will be given on Tuesday, October 24, 2017 in San Diego, CA.
Dr. Marchand looks forward to seeing many of his colleagues at the conference and as always is excited about garnering attention for minimally invasive surgery!
You can preview the video here: https://youtu.be/Iqd4aFJOPQQ
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###
Related posts
